在97,691个全基因组中遗传性血液形成的原因
在PubMed上查看摘要
概括
此摘要是机器生成的。年龄增长会增加慢性疾病的风险. 这项研究确定了影响克隆性血液形成 (CHIP) 的遗传因素,这是一种与癌症和心脏病相关的疾病,揭示了生殖系变异如何影响干细胞功能.
科学领域
- 基因组学
- 血液学
- 老龄化研究
背景情况
- 年龄是慢性疾病的主要危险因素,
- 不确定潜力的克隆性血液形成 (CHIP),其特征是血液形成干细胞的与年龄相关的体质突变,与血液癌症和冠状动脉疾病有关.
- 了解CHIP的遗传基础对于阐明与衰老相关的疾病风险至关重要.
研究的目的
- 在CHIP的发展中研究生殖基因和体质突变之间的相互作用.
- 确定与CHIP状态及其驱动基因相关的遗传变异和基因位点.
- 探索生殖系遗传变异对造血干细胞 (HSC) 功能和CHIP病变的功能影响.
主要方法
- 分析了TOPMed计划中97,691名不同参与者的高覆盖全基因组序列.
- 鉴定CHIP个体和血液细胞,脂质和炎症特征的关联分析.
- 全基因组关联研究 (GWAS) 以确定与CHIP相关的生殖系遗传变异,随后对包括TET2基因在内的已识别的基因位置进行in silico和in vitro评估.
主要成果
- 发现了4,229名CHIP患者.
- 在CHIP驱动基因和血液细胞,脂质和炎症特征之间发现了特定的关联.
- 确定了与CHIP身份相关的三个遗传位点,其中包括特定于非洲血统的个体的TET2位点.
- 鉴定出一种干扰TET2远端增强剂的致病性生殖系变体,导致HSC自我更新的增加.
结论
- 生殖系遗传变异显著影响HSC功能,并为CHIP的发展做出贡献.
- CHIP是通过特定于克隆造血的机制产生的,并且与组织间的体质突变共享.
- 这项研究提供了与衰老相关疾病的遗传基础,并强调了生殖基因在CHIP中的作用.
相关概念视频
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
The process of blood cell formation is called hematopoiesis. Hematopoiesis starts early during development, on the seventh day of embryogenesis. This phase of hematopoiesis is called the primitive wave, wherein the extraembryonic yolk sac allows the production of erythroid cells and endothelial cells from a common precursor called hemangioblast. The erythroid cells provide oxygen to support the growth of the rapidly dividing embryo. Hemangioblasts later develop into hematopoietic stem cells or...
Commitment is the process whereby stem cells:
lose their ability to form all cell types and
irreversibly change into a specific type.
The multipotent hematopoietic stem cells, (HSCs), differentiate into the multipotent hematopoietic progenitor cells, (HPCs). The HPCs express many lineage-specific cytokine receptors. Each of these receptors binds specific cytokines, activates distinct signaling pathways, and expresses a particular gene set. The HPCs further differentiate to...
The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...
Epigenetics is the study of inherited changes in a cell's phenotype without changing the DNA sequences. It provides a form of memory for the differential gene expression pattern to maintain cell lineage, position-effect variegation, dosage compensation, and maintenance of chromatin structures such as telomeres and centromeres. For example, the structure and location of the centromere on chromosomes are epigenetically inherited. Its functionality is not dictated or ensured by the underlying...
Hematopoiesis, or blood cell production, is a vital biological process that begins early in embryonic development and continues throughout life. This process generates the various types of cells found in blood, including red blood cells, white blood cells, and platelets from hematopoietic stem cells (HSCs).
Developmental Phases of Hematopoiesis
Initially, HSCs are formed in the embryonic yolk sac, a critical site for early blood cell production. These stem cells subsequently migrate to other...

